EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From PEGylation to Next-Generation Polymers: Overcoming Biological Barriers—A Review

Rizvangul Iminova, Gulzat Berganayeva iD, Aliya Zhurtbayeva, Lazzat Abdurakhmanova, Almagul Almabekova, Daniil Shepilov iD, Gulzira Vassilina, Akmaral Nurmahanova, Gulfairuz Kairalapova, Moldyr Dyusebaeva

Molecules · 2026

DOI: 10.3390/molecules31040675 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2026. Verfasst von Rizvangul Iminova und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry and Chemical Technology, Al-Farabi Kazakh National University, Almaty 050040/A15E3B4, Kazakhstan. Hauptthemen laut MEDLINE: Polyethylene Glycols, Polymers, Drug Delivery Systems, Drug Carriers. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Poly(ethylene glycol) (PEG) has long stood as the prevailing standard in drug delivery, celebrated for its capacity to enhance solubility, extend circulation, and improve pharmacological performance. Nevertheless, the emergence of anti-PEG antibodies, accelerated clearance, and limited biodegradability increasingly undermine its role as a universal solution. In response, a new generation of polymers has been developed to address these shortcomings, offering the potential to sustain or surpass PEG’s benefits while mitigating immunogenicity, improving biocompatibility, and enabling finer control over therapeutic fate. This review examines current research to articulate a coherent perspective on the replacement of PEG, tracing how advances in polymer design are reshaping the foundations of targeted drug delivery. Taken together, these developments signal not only a corrective to the limitations of PEG but also a broader paradigm shift toward safer, more versatile, and clinically translatable systems that define the next frontier in precision therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polyethylene GlycolsPolymersDrug Delivery SystemsDrug CarriersHumansAnimalsBiocompatible Materials

Stichwörter der Autor:innen

PEG alternativesbiodegradable polymerslow-immunogenic polymersnanocarrierstargeted cancer therapy

Substanzen

Polyethylene GlycolsPolymersDrug CarriersBiocompatible Materials

Autor:innen und Institutionen

  • Faculty of Chemistry and Chemical Technology, Al-Farabi Kazakh National University, Almaty 050040/A15E3B4, Kazakhstan.
  • School of Pharmacy, Department of Chemistry, Asfendiyarov Kazakh National Medical University, Almaty 050012/A35B8H9, Kazakhstan.
  • Faculty of Biotechnology and Chemical Technologies, Almaty Technological University, Almaty 050012/A05B8Y5, Kazakhstan.
  • Faculty of Biology and Biotechnology, Al-Farabi Kazakh National University, Almaty 050040/A15E3C7, Kazakhstan.

ORCID-Profile: Gulzat Berganayeva, Daniil Shepilov

Zitieren

APA

Iminova, R., Berganayeva, G., Zhurtbayeva, A., Abdurakhmanova, L., Almabekova, A., Shepilov, D., Vassilina, G., Nurmahanova, A., Kairalapova, G., & Dyusebaeva, M. (2026). From PEGylation to Next-Generation Polymers: Overcoming Biological Barriers—A Review. Molecules. https://doi.org/10.3390/molecules31040675

Vancouver

Iminova R, Berganayeva G, Zhurtbayeva A, Abdurakhmanova L, Almabekova A, Shepilov D, et al. From PEGylation to Next-Generation Polymers: Overcoming Biological Barriers—A Review. Molecules. 2026. doi:10.3390/molecules31040675

BibTeX
@article{Iminova2026,
  author = {Iminova, Rizvangul and Berganayeva, Gulzat and Zhurtbayeva, Aliya and Abdurakhmanova, Lazzat and Almabekova, Almagul and Shepilov, Daniil and Vassilina, Gulzira and Nurmahanova, Akmaral and Kairalapova, Gulfairuz and Dyusebaeva, Moldyr},
  title = {From PEGylation to Next-Generation Polymers: Overcoming Biological Barriers—A Review},
  journal = {Molecules},
  year = {2026},
  doi = {10.3390/molecules31040675}
}
Kostenlos starten →